Correlation Between Molecular Templates and Avalo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Templates and Avalo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Templates and Avalo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Templates and Avalo Therapeutics, you can compare the effects of market volatilities on Molecular Templates and Avalo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Templates with a short position of Avalo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Templates and Avalo Therapeutics.
Diversification Opportunities for Molecular Templates and Avalo Therapeutics
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Molecular and Avalo is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Templates and Avalo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avalo Therapeutics and Molecular Templates is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Templates are associated (or correlated) with Avalo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avalo Therapeutics has no effect on the direction of Molecular Templates i.e., Molecular Templates and Avalo Therapeutics go up and down completely randomly.
Pair Corralation between Molecular Templates and Avalo Therapeutics
Given the investment horizon of 90 days Molecular Templates is expected to under-perform the Avalo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Molecular Templates is 1.69 times less risky than Avalo Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Avalo Therapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 124,800 in Avalo Therapeutics on August 30, 2024 and sell it today you would lose (123,845) from holding Avalo Therapeutics or give up 99.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Templates vs. Avalo Therapeutics
Performance |
| Timeline |
| Molecular Templates |
| Avalo Therapeutics |
Molecular Templates and Avalo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Templates and Avalo Therapeutics
The main advantage of trading using opposite Molecular Templates and Avalo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Templates position performs unexpectedly, Avalo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avalo Therapeutics will offset losses from the drop in Avalo Therapeutics' long position.| Molecular Templates vs. Bright Minds Biosciences | Molecular Templates vs. HP Inc | Molecular Templates vs. Intel | Molecular Templates vs. Chevron Corp |
| Avalo Therapeutics vs. AnaptysBio | Avalo Therapeutics vs. Arcellx | Avalo Therapeutics vs. Structure Therapeutics American | Avalo Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |